Obstetrics & Gynaecology
Urinary Incontinence
Urinary Incontinence clinical pathway.
Source: NICE; RCOG; ICS — NICE NG123 (updated 2025)
Step 1 of ~4
info
Assessment & Classification
Assessment:
• Bladder diary (≥3 days)
• Pelvic examination
• Urine dipstick/culture
• Post-void residual (if indicated)
Red Flags:
• Haematuria
• Pain
• Recurrent UTIs
• Neurological symptoms
• Pelvic mass
• Post-void residual concern
Types:
• Stress incontinence: Leakage with cough, sneeze, exercise
• Urgency incontinence (OAB): Urgency, frequency, nocturia, leakage
• Mixed incontinence: Both stress and urgency components
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Methylene Blue · Guanylate Cyclase / Nitric Oxide Pathway Inhibitor
- Sodium phenylbutyrate · Ammonia scavenger (alternative pathway)
- Marstacimab · Anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody
- Nitrofurantoin (UTI Treatment) · Urinary Antiseptic
- Human Chorionic Gonadotrophin (hCG) · Gonadotrophin (Ovulation Trigger)
- Nitrofurantoin (UTI in Pregnancy) · Urinary Antibiotic — Obstetric
Decision support only. Always apply local guidelines and clinical judgement.